A safe and efficient method to retrieve mesenchymal stem cells from three-dimensional fibrin gels

Tissue Engineering - Part C: Methods

Volumn 20, Issue 3, 2014, Pages 252-263

  Carrion, Bita ^a   Janson, Isaac A ^a   Kong, Yen P ^a   Putnam, Andrew J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELLS; FLOWCHARTING; GENE ENCODING; SYNCHROTRONS; THREE DIMENSIONAL; TISSUE; TISSUE ENGINEERING;

COST-EFFECTIVE METHODS; EXTRACELLULAR MATRICES; FIBRINOLYTIC ACTIVITY; PHYSIOLOGICAL ENVIRONMENT; PROTEIN-BASED MATERIALS; THERAPEUTIC APPLICATION; TISSUE CULTURE PLASTICS; TISSUE ENGINEERING APPLICATIONS;

CELL CULTURE;

FIBRIN; FIBRINOGEN;

ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; FIBRINOLYSIS; GEL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THREE DIMENSIONAL CULTURE;

ADIPOGENESIS; CELL LINEAGE; CELL SEPARATION; FIBRIN; GELS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; POLYMERASE CHAIN REACTION; SUBTILISINS;

EID: 84896857670     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2013.0051     Document Type: Article

References (87)

1. Rao, M.S., and Mattson, M.P. Stem cells and aging: expanding the possibilities. Mech Ageing Dev 122, 713, 2001.
2. Sarugaser, R., Ennis, J., Stanford, W.L., and Davies, J.E. Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs). Methods Mol Biol 482, 269, 2009.
3. De Coppi, P., Bartsch, G., Jr., Siddiqui, M.M., Xu, T., Santos, C.C., Perin, L., Mostoslavsky, G., Serre, A.C., Snyder, E.Y., Yoo, J.J., Furth, M.E., Soker, S., and Atala, A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25, 100, 2007.
4. Yen, B.L., Chang, C.J., Liu, K.J., Chen, Y.C., Hu, H.I., Bai, C.H., and Yen, M.L. Brief report-human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 27, 451, 2009.
5. Yen, M.L., Hou, C.H., Peng, K.Y., Tseng, P.C., Jiang, S.S., Shun, C.T., Chen, Y.C., and Kuo, M.L. Efficient derivation & concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplant 20, 1529, 2011.
6. Caplan, A.I., and Correa, D. The MSC: an injury drugstore. Cell Stem Cell 9, 11, 2011.
7. Lutolf, M.P., and Blau, H.M. Artificial stem cell niches. Adv Mater 21, 3255, 2009.
8. Gilbert, P.M., and Blau, H.M. Engineering a stem cell house into a home. Stem Cell Res Ther 2, 3, 2011.
9. Banfi, A., Muraglia, A., Dozin, B., Mastrogiacomo, M., Cancedda, R., and Quarto, R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28, 707, 2000.
10. Baxter, M.A., Wynn, R.F., Jowitt, S.N., Wraith, J.E., Fairbairn, L.J., and Bellantuono, I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22, 675, 2004.
11. Reiser, J., Zhang, X.Y., Hemenway, C.S., Mondal, D., Pradhan, L., and La Russa, V.F. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 5, 1571, 2005.
12. Mendez-Ferrer, S., Michurina, T.V., Ferraro, F., Mazloom, A.R., Macarthur, B.D., Lira, S.A., Scadden, D.T., Ma'ayan, A., Enikolopov, G.N., and Frenette, P.S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829, 2010.
13. Markway, B.D., Tan, G.K., Brooke, G., Hudson, J.E., Cooper-White, J.J., and Doran, M.R. Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant 19, 29, 2010.
14. Wang, W., Itaka, K., Ohba, S., Nishiyama, N., Chung, U.I., Yamasaki, Y., and Kataoka, K. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials 30, 2705, 2009.
15. Jahn, K., Richards, R.G., Archer, C.W., and Stoddart, M.J. Pellet culture model for human primary osteoblasts. Eur Cell Mater 20, 149, 2010.
16. Ungrin, M.D., Joshi, C., Nica, A., Bauwens, C., and Zandstra, P.W. Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One 3, e1565, 2008.
17. Cook, M.M., Futrega, K., Osiecki, M., Kabiri, M., Kul, B., Rice, A., Atkinson, K., Brooke, G., and Doran, M. Micromarrows-three-dimensional coculture of hematopoietic stem cells and mesenchymal stromal cells. Tissue Eng Part C Methods 18, 319, 2012.
18. King, J.A., and Miller, W.M. Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol 11, 394, 2007.
19. Breen, A., O'Brien, T., and Pandit, A. Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev 15, 201, 2009.
20. Ho, W., Tawil, B., Dunn, J.C., and Wu, B.M. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12, 1587, 2006.
21. Christman, K.L., Vardanian, A.J., Fang, Q., Sievers, R.E., Fok, H.H., and Lee, R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44, 654, 2004.
22. Syedain, Z.H., Bjork, J., Sando, L., and Tranquillo, R.T. Controlled compaction with ruthenium-catalyzed photochemical cross-linking of fibrin-based engineered connective tissue. Biomaterials 30, 6695, 2009.
23. Huang, N.F., Lam, A., Fang, Q., Sievers, R.E., Li, S., and Lee, R.J. Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med 4, 527, 2009.
24. Ryu, J.H., Kim, I.K., Cho, S.W., Cho, M.C., Hwang, K.K., Piao, H., Piao, S., Lim, S.H., Hong, Y.S., Choi, C.Y., Yoo, K.J., and Kim, B.S. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26, 319, 2005.
25. Ruger, B.M., Breuss, J., Hollemann, D., Yanagida, G., Fischer, M.B., Mosberger, I., Chott, A., Lang, I., Davis, P.F., Hocker, P., and Dettke, M. Vascular morphogenesis by adult bone marrow progenitor cells in three-dimensional fibrin matrices. Differentiation 76, 772, 2008.
26. Bensaid, W., Triffitt, J.T., Blanchat, C., Oudina, K., Sedel, L., and Petite, H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24, 2497, 2003.
27. Catelas, I., Sese, N., Wu, B.M., Dunn, J.C., Helgerson, S., and Tawil, B. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 12, 2385, 2006.
28. Dickhut, A., Gottwald, E., Steck, E., Heisel, C., and Richter, W. Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo. Front Biosci 13, 4517, 2008.
29. Baumgartner, L., Arnhold, S., Brixius, K., Addicks, K., and Bloch, W. Human mesenchymal stem cells: influence of oxygen pressure on proliferation and chondrogenic differentiation in fibrin glue in vitro. J Biomed Mater Res A 93, 930, 2010.
30. Ghajar, C.M., Blevins, K.S., Hughes, C.C., George, S.C., and Putnam, A.J. Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng 12, 2875, 2006.
31. Ghajar, C.M., Chen, X., Harris, J.W., Suresh, V., Hughes, C.C., Jeon, N.L., Putnam, A.J., and George, S.C. The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J 94, 1930, 2008.
32. Ghajar, C.M., Kachgal, S., Kniazeva, E., Mori, H., Costes, S.V., George, S.C., and Putnam, A.J. Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res 316, 813, 2010.
33. Kachgal, S., and Putnam, A.J. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 14, 47, 2011.
34. Kniazeva, E., Kachgal, S., and Putnam, A.J. Effects of extracellular matrix density and mesenchymal stem cells on neovascularization in vivo. Tissue Eng Part A 17, 905, 2011.
35. Carrion, B., Huang, C.P., Ghajar, C.M., Kachgal, S., Kniazeva, E., Jeon, N.L., and Putnam, A.J. Recreating the peri-vascular niche ex vivo using a microfluidic approach. Biotechnol Bioeng 107, 1020, 2010.
36. Kachgal, S., Carrion, B., Janson, I.A., and Putnam, A.J. Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP. J Cell Physiol 227, 3546, 2012.
37. Kossack, N., Meneses, J., Shefi, S., Nguyen, H.N., Chavez, S., Nicholas, C., Gromoll, J., Turek, P.J., and Reijo-Pera, R.A. Isolation and characterization of pluripotent human spermatogonial stem cell-derived cells. Stem Cells 27, 138, 2009.
38. Sun, N., Panetta, N.J., Gupta, D.M., Wilson, K.D., Lee, A., Jia, F., Hu, S., Cherry, A.M., Robbins, R.C., Longaker, M.T., and Wu, J.C. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 106, 15720, 2009.
39. Huang, G.T., Yamaza, T., Shea, L.D., Djouad, F., Kuhn, N.Z., Tuan, R.S., and Shi, S. Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A 16, 605, 2010.
40. Farias, V.A., Linares-Fernandez, J.L., Penalver, J.L., Paya Colmenero, J.A., Ferron, G.O., Duran, E.L., Fernandez, R.M., Olivares, E.G., O'Valle, F., Puertas, A., Oliver, F.J., and Ruiz de Almodovar, J.M. Human umbilical cord stromal stem cell express CD10 and exert contractile properties. Placenta 32, 86, 2011.
41. Yang, Y.I., Kim, H.I., Shelby, J., Choi, M.Y., Jang, S.H., Kim, J.T., Jang, W.H., Choi, C.S., and Cheong, S.H. Fibrin matrixsupported three-dimensional organ culture of adipose tissue for selective outgrowth, expansion, and isolation of adiposederived stem cells. Acta Biomater 7, 4109, 2011.
42. Choi, M.Y., Kim, H.I., Yang, Y.I., Kim, J.T., Jang, S.H., Park, C.M., Jang, W.H., Youn, Y.C., Cheong, S.H., Choi, C.S., Kim, D.K., and Lee, S.J. The isolation and in situ identification of MSCs residing in loose connective tissues using a nichepreserving organ culture system. Biomaterials 33, 4469, 2012.
43. Urano, T., Ihara, H., Umemura, K., Suzuki, Y., Oike, M., Akita, S., Tsukamoto, Y., Suzuki, I., and Takada, A. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem 276, 24690, 2001.
44. Sumi, H., Hamada, H., Tsushima, H., Mihara, H., and Muraki, H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia 43, 1110, 1987.
45. Fujita, M., Nomura, K., Hong, K., Ito, Y., Asada, A., and Nishimuro, S. Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem Biophys Res Commun 197, 1340, 1993.
46. McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., and Chen, C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6, 483, 2004.
47. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
48. Prockop, D.J.P., Donald G.; Bunnell, B.A., ed. Mesenchymal Stem Cells: Methods and Protocols. Totowa, NJ: Humana Press, 2008.
49. Rao, R.R., Jiao, A., Kohn, D.H., and Stegemann, J.P. Exogenous mineralization of cell-seeded and unseeded collagenchitosan hydrogels using modified culture medium (vol 8, pg 1560, 2012). Acta Biomater 8, 2417, 2012.
50. Ter Brugge, P.J., and Jansen, J.A. In vitro osteogenic differentiation of rat bone marrow cells subcultured with and without dexamethasone. Tissue Eng 8, 321, 2002.
51. Schmittgen, T.D., and Livak, K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101, 2008.
52. Fink, T., Lund, P., Pilgaard, L., Rasmussen, J.G., Duroux, M., and Zachar, V. Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation and hypoxic exposure. BMC Mol Biol 9, 98, 2008.
53. Krause, U., Seckinger, A., and Gregory, C.A. Assays of osteogenic differentiation by cultured human mesenchymal stem cells. Methods Mol Biol 698, 215, 2011.
54. Stacey, D.H., Hanson, S.E., Lahvis, G., Gutowski, K.A., and Masters, K.S. In vitro adipogenic differentiation of preadipocytes varies with differentiation stimulus, culture dimensionality, and scaffold composition. Tissue Eng Part A 15, 3389, 2009.
55. Tarnowski, B.I., Sens, D.A., Nicholson, J.H., Hazenmartin, D.J., Garvin, A.J., and Sens, M.A. Automatic quantitation of cell-growth and determination of mitotic index using DAPI nuclear staining. Pediatr Pathol 13, 249, 1993.
56. Lutolf, M.P., Gilbert, P.M., and Blau, H.M. Designing materials to direct stem-cell fate. Nature 462, 433, 2009.
57. Grainger, S.J., and Putnam, A.J. Assessing the permeability of engineered capillary networks in a 3D culture. PLoS One 6, e22086, 2011.
58. Kocholaty, W., Ellis, W.W., and Jensen, H. Activation of plasminogen by trypsin and plasmin. Blood 7, 882, 1952.
59. T'Joen, V., Declercq, H., and Cornelissen, M. Expansion of human embryonic stem cells: a comparative study. Cell Prolif 44, 462, 2011.
60. Marley, M.S.D., Givens, M.D., Galik, P.K., Riddell, K.P., Looney, C.R., and Stringfellow, D.A. Efficacy of a recombinant trypsin product against bovine herpesvirus I associated with in vivo-and in vitro-derived bovine embryos. Theriogenology 69, 746, 2008.
61. Kanematsu, D., Shofuda, T., Yamamoto, A., Ban, C., Ueda, T., Yamasaki, M., and Kanemura, Y. Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta. Differentiation 82, 77, 2011.
62. Kim, W.K., Meliton, V., Amantea, C.M., Hahn, T.J., and Parhami, F. 20(S)-Hydroxycholesterol inhibits PPAR gamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism. J Bone Miner Res 22, 1711, 2007.
63. Psaltis, P.J., Paton, S., See, F., Arthur, A., Martin, S., Itescu, S., Worthley, S.G., Gronthos, S., and Zannettino, A.C.W. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J Cell Physiol 223, 530, 2010.
64. Ho, S.T., Cool, S.M., Hui, J.H., and Hutmacher, D.W. The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials 31, 38, 2010.
65. Jung, S.N., Rhie, J.W., Kwon, H., Jun, Y.J., Seo, J.W., Yoo, G., Oh, D.Y., Ahn, S.T., Woo, J., and Oh, J. In vivo cartilage formation using chondrogenic-differentiated human adipose-derived mesenchymal stem cells mixed with fibrin glue. J Craniofac Surg 21, 468, 2010.
66. Wu, X., Ren, J., and Li, J. Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine. Cytotherapy 14, 555, 2012.
67. Diederichs, S., Baral, K., Tanner, M., and Richter, W. Interplay between local versus soluble transforming growth factor-beta and fibrin scaffolds: role of cells and impact on human mesenchymal stem cell chondrogenesis. Tissue Eng Part A 18, 1140, 2012.
68. Lijnen, H.R. Elements of the fibrinolytic system. Ann N Y Acad Sci 936, 226, 2001.
69. Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R., and Weiss, S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365, 1998.
70. Hotary, K.B., Yana, I., Sabeh, F., Li, X.Y., Holmbeck, K., Birkedal-Hansen, H., Allen, E.D., Hiraoka, N., and Weiss, S.J. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and-independent processes. J Exp Med 195, 295, 2002.
71. Brendlerschwaab, S.Y., Schmezer, P., Liegibel, U., Weber, S., Michalek, K., Tompa, A., and Poolzobel, B.L. Cells of different tissues for in-vitro and in-vivo studies in toxicology-compilation of isolation methods. Toxicol In Vitro 8, 1285, 1994.
72. MacCoss, M.J., Wu, C.C., and Yates, J.R. Probability-based validation of protein identifications using a modified SEQUEST algorithm. Anal Chem 74, 5593, 2002.
73. Shao, L.J., Feng, W., Sun, Y., Bai, H., Liu, J., Currie, C., Kim, J.J., Gama, R., Wang, Z., Qian, Z.J., Liaw, L., and Wu, W.S. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 19, 296, 2009.
74. Huang, H.L., Hsing, H.W., Lai, T.C., Chen, Y.W., Lee, T.R., Chan, H.T., Lyu, P.C., Wu, C.L., Lu, Y.C., Lin, S.T., Lin, C.W., Lai, C.H., Chang, H.T., Chou, H.C., and Chan, H.L. Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci 17, 36, 2010.
75. Kolev, K., Tenekedjiev, K., Komorowicz, E., and Machovich, R. Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation. J Biol Chem 272, 13666, 1997.
76. Fujita, M., Ito, Y., Hong, K., and Nishimuro, S. Characterization of nattokinase-degraded products from human fibrinogen or cross-linked fibrin. Fibrinolysis 9, 157, 1995.
77. Giordano, A., Galderisi, U., and Marino, I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211, 27, 2007.
78. Wagner, J., Kean, T., Young, R., Dennis, J.E., and Caplan, A.I. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20, 531, 2009.
79. Simmons, C.A., Alsberg, E., Hsiong, S., Kim, W.J., and Mooney, D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562, 2004.
80. Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., Fujii, T., Uematsu, M., Ohgushi, H., Yamagishi, M., Tokudome, T., Mori, H., Miyatake, K., and Kitamura, S. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128, 2005.
81. Silva, G.V., Litovsky, S., Assad, J.A., Sousa, A.L., Martin, B.J., Vela, D., Coulter, S.C., Lin, J., Ober, J., Vaughn, W.K., Branco, R.V., Oliveira, E.M., He, R., Geng, Y.J., Willerson, J.T., and Perin, E.C. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111, 150, 2005.
82. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543, 2004.
83. Caplan, A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213, 341, 2007.
84. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
85. Parekkadan, B., and Milwid, J.M. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12, 87, 2010.
86. Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A.M., and Silberstein, L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24, 1030, 2006.
87. Colley, H., McArthur, S.L., Stolzing, A., and Scutt, A. Culture on fibrin matrices maintains the colony-forming capacity and osteoblastic differentiation of mesenchymal stem cells. Biomed Mater 7, 2012.